Catalio Capital Management

An AI and synthetic-biology platform that designs and engineers antibody therapeutics.

Basecamp Research builds biological AI models from genomic data to help design therapeutics, including protein-based medicines.

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

Evvy combines at-home vaginal microbiome testing with clinician-reviewed results, personalized next steps and optional treatment and coaching for women’s health.

Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity.

Developing best-in-class radiopharmaceuticals for cancer treatment

AdvanCell develops targeted alpha radiopharmaceuticals for cancer using Lead-212, with integrated isotope supply and manufacturing.

AI-enabled virtual specialty care platform for managing high-cost chronic conditions

Develops treatments for patients suffering from thromboembolic disease

Provides non-CPAP alternative for Obstructive Sleep Apnea treatment

Develops medicines targeting historically undruggable protein targets in cancer